XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Operating expenses:        
Research and development $ 55,251 $ 34,670 $ 151,918 $ 109,570
General and administrative 7,022 7,609 22,556 21,247
Total operating expenses 62,273 42,279 174,474 130,817
Loss from operations (62,273) (42,279) (174,474) (130,817)
Other (expense) income:        
Interest income 2,189 903 5,890 1,575
Other income (expense), net (126) (9) (715) (30)
Total other (expense) income, net 2,063 894 5,175 1,545
Net loss $ (60,210) $ (41,385) $ (169,299) $ (129,272)
Net loss per share - basic $ (0.99) $ (0.8) $ (2.86) $ (2.5)
Net loss per share - diluted $ (0.99) $ (0.8) $ (2.86) $ (2.5)
Weighted-average common shares outstanding, basic 61,109,917 51,795,446 59,107,795 51,692,899
Weighted-average common shares outstanding, diluted 61,109,917 51,795,446 59,107,795 51,692,899
Comprehensive loss:        
Net loss $ (60,210) $ (41,385) $ (169,299) $ (129,272)
Other comprehensive loss:        
Unrealized gains (losses) on marketable securities, net 43 173 558 (714)
Comprehensive loss $ (60,167) $ (41,212) $ (168,741) $ (129,986)